Recent Additions

Mon, Feb 03, 2020 - 10:48
February 3, 2020 – The National Viral Hepatitis Roundtable (NVHR), a national coalition working to eliminate viral hepatitis, and the Center for Health Law and Policy Innovation of Harvard Law School (CHLPI) today commended Montana for removing discriminatory restrictions on access to treatment for the hepatitis C virus (HCV). Hepatitis C is the nation’s deadliest infectious disease and Montana’s restrictions on access to a treatment had been among the most severe in the country.
Fri, Jan 31, 2020 - 08:26
Washington, D.C. (January 31, 2020) – The National Viral Hepatitis Roundtable (NVHR), a national coalition working to eliminate viral hepatitis, today commended the U.S. Centers for Disease Control and Prevention (CDC) and the U.S. Department of Health and Human Services (HHS) for committing to fund programs that ‘End the HIV Epidemic’ by addressing HIV, viral hepatitis, overdose, and syringe services in an integrated fashion. Read the Press Release
Thu, Jan 23, 2020 - 17:27
The National Viral Hepatitis Roundtable (NVHR), a national coalition working to eliminate viral hepatitis, today applauded the National Academies of Sciences, Engineering, and Medicine (NASEM), for its report analyzing the simultaneous opioid use disorder (OUD) and infectious disease epidemics in the U.S. and calling for a congressionally funded, integrated approach to addressing the epidemics.
Thu, Nov 07, 2019 - 09:58
NVHR and public health experts will provide an update to the latest “Hepatitis C: State of Medicaid Access” report during a panel discussion on Monday, November 11.
Wed, Oct 09, 2019 - 16:32
WASHINGTON, DC & BOSTON, MA (Oct. 10, 2019) – The National Viral Hepatitis Roundtable (NVHR) and the Center for Health Law and Policy Innovation of Harvard Law School (CHLPI) today launched an update to “Hepatitis C: State of Medicaid Access,” an interactive project grading all 50 state Medicaid programs, as well as the District of Columbia and Puerto Rico, according to access to curative treatments for hepatitis C, the nation’s deadliest infectious disease. NVHR, Harvard and other leading viral hepatitis advocates today also sent a letter to the U.S. Centers for Medicare and Medicaid Services (CMS) urging the agency to take action to end discriminatory state treatment restrictions, which, according to CMS guidance, violate federal Medicaid law.